Evaluation of the sensitivities of six triple-negative breast cancer (TNBC) cell lines to 23 different PI3K/AKT/mTOR inhibitors or to a MEK inhibitor (trametinib). Dataset 1 of 2: GR values. - Dataset (ID:20364)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell line | Drug name | Experimental replicate | Timepoint | Drug concentration | Live cell count | Average live cell count, DMSO control | Average live cell count (time = 0) | Log10(drug concentration) | GR value | Relative cell count (treatment versus DMSO) | Cell doublings (DMSO control) | Experiment name |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hs 578T | ZSTK474 | 2 | 72 | 0.32 | 2154.3 | 3668.0 | 624.7 | -0.495 | 0.624 | 0.587 | 2.554 | Hs578T ZSTK474 2 |
| Hs 578T | ZSTK474 | 2 | 72 | 0.1 | 2555.5 | 3668.0 | 624.7 | -1.0 | 0.736 | 0.697 | 2.554 | Hs578T ZSTK474 2 |
| Hs 578T | ZSTK474 | 2 | 72 | 0.032 | 3160.0 | 3668.0 | 624.7 | -1.49 | 0.887 | 0.862 | 2.554 | Hs578T ZSTK474 2 |
| Hs 578T | ZSTK474 | 2 | 72 | 0.01 | 3360.0 | 3668.0 | 624.7 | -2.0 | 0.932 | 0.916 | 2.554 | Hs578T ZSTK474 2 |
| Hs 578T | ZSTK474 | 2 | 72 | 0.0032 | 3474.8 | 3668.0 | 624.7 | -2.49 | 0.958 | 0.947 | 2.554 | Hs578T ZSTK474 2 |
| Hs 578T | ZSTK474 | 2 | 72 | 0.001 | 3461.3 | 3668.0 | 624.7 | -3.0 | 0.955 | 0.944 | 2.554 | Hs578T ZSTK474 2 |